Home > Business Cases > Discovering new indications for drug-drug combinations
Discovering new indications for drug-drug combinations
-
Mid-Pharma company has developed new molecules by co-crystallizing known drugs (for example, crystals of duloxetine+naproxen, atorvastatin+atenolol, and many others).
-
They want to systematically explore synergistic potentiation of therapeutic uses, and to explore new unexpected combinations.
-
Anaxomics prepares in 2 months a full report providing potential new indications for more than 20 combinations, with a post-hoc scientific rationale of the main ones.
-
Results are presented in a readable and clear way for the client, helping them take correct decisions.
Please, contact us here to request more information.
